ctrl K

Watchlist Price Alert

Panbela Therapeutics Inc. (PBLA)

OTC: PBLA · Real-Time Price · USD

0.32

0.00 (0.00%)

At close: Apr 04, 2025, 3:56 PM

Panbela Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	25.65M	35.73M	10.01M	5.75M	4.32M	3.89M	6.02M	5.17M
Gross Profit	-25.65M	-35.73M	-10.01M	-5.75M	-4.32M	-3.89M	-6.02M	-5.17M
Operating Income	-51.29M	-34.09M	-10.01M	-5.75M	-4.32M	-3.89M	-6.02M	-5.17M
Interest Income	123K	14K	1K	17.00	2.19K	n/a	1K	2K
Pretax Income	-25.45M	-35.05M	-10.62M	-5.06M	-6.62M	-6.16M	-10.91M	-5.45M
Net Income	-25.26M	-34.93M	-10.13M	-4.77M	-6.2M	-5.91M	-10.37M	-5.11M
Selling & General & Admin	5.03M	6.04M	4.59M	3.25M	1.97M	2.11M	3.42M	2.66M
Research & Development	20.61M	28.05M	5.42M	2.5M	2.35M	1.78M	2.59M	2.5M
Other Expenses	n/a	-682K	-602K	605K	-99K	-508K	n/a	n/a
Operating Expenses	25.65M	34.09M	10.01M	5.75M	4.32M	3.84M	6.02M	5.17M
Interest Expense	-317K	288K	11K	17K	2.19M	1.81M	1.62M	180K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	51.29M	34.09M	10.01M	5.75M	4.32M	3.84M	6.02M	5.17M
Income Tax Expense	-186K	-116K	-488K	-295K	-415K	-254K	-536K	-341K
Shares Outstanding (Basic)	108.69	857.28	487.88	322.20	237.51	3.88K	2.97K	2.59K
Shares Outstanding (Diluted)	108.69	857.28	487.88	322.20	237.51	3.88K	2.97K	2.59K
EPS (Basic)	-232.43K	-40.75K	-20.77K	-14.8K	-26.1K	-1.52K	-3.49K	-1.97K
EPS (Diluted)	-232.43K	-40.75K	-20.77K	-14.8K	-26.1K	-1.52K	-3.49K	-1.97K
EBITDA	-51.29M	-34.76M	-10.61M	-5.15M	-4.42M	-1.76M	-6.02M	-5.17M
EBIT	-25.77M	-34.76M	-10.61M	-5.05M	-4.42M	-4.34M	-9.29M	-5.27M
Depreciation & Amortization	n/a	16.36K	10.01K	5.75K	4.32K	3.89K	6.02K	5.17K